Clinical Trial Update: Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 clinical trial evaluating sulfasalazine for the treatment of Primary Sclerosing Cholangitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• Sulfasalazine (Sulfasalazine)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Primary Sclerosing Cholangitis | Phase 2 | Status: COMPLETED